Literature DB >> 12553374

Vaccination of mice with MUC1 cDNA suppresses the development of lung metastases.

Mika Kamata1, Kaori Denda-Nagai, Nobuyoshi Kubota, Satoshi Aida, Kazuyoshi Takeda, Tatsuro Irimura.   

Abstract

C57BL/6 mice were immunized intradermally with various doses of purified pCEP4 plasmid DNA containing full-length MUC1 cDNA (22 tandem repeats). Mice immunized with MUC1 DNA three times at weekly intervals had serum antibodies to a synthetic peptide corresponding to the tandem repeats of MUC1. The antibody titer correlated with the plasmid DNA dose. After the third immunization mice were injected intravenously with 5 x 10(5) 16-F10 melanoma cells that had been stably transfected with MUC1 cDNA (F10-MUC1-C8 clone cells). The number of lung metastatic nodules three weeks after inoculation of F10-MUC1-C8 cells was significantly lower in mice immunized with MUC1 plasmid DNA than in mice immunized with the vector DNA alone. Thus, the suppression of lung metastasis was antigen-specific. In vivo depletion of lymphocyte subpopulations by specific antibodies revealed that natural killer cells are the major effector cells responsible for the suppression of lung metastasis. CD4+ cells and CD8+ cells apparently played some roles too.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12553374     DOI: 10.1023/a:1021332932531

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  64 in total

1.  Gene gun-mediated DNA vaccination induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the liver and lungs.

Authors:  C H Chen; H Ji; K W Suh; M A Choti; D M Pardoll; T C Wu
Journal:  Gene Ther       Date:  1999-12       Impact factor: 5.250

2.  DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity.

Authors:  J S Boyle; A Silva; J L Brady; A M Lew
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

3.  In vivo induction of specific cytotoxic T lymphocytes in mice and rhesus macaques immunized with DNA vector encoding an HIV epitope fused with hepatitis B surface antigen.

Authors:  S Le Borgne; M Mancini; R Le Grand; M Schleef; D Dormont; P Tiollais; Y Rivière; M L Michel
Journal:  Virology       Date:  1998-01-20       Impact factor: 3.616

4.  Immunostimulatory DNA sequences necessary for effective intradermal gene immunization.

Authors:  Y Sato; M Roman; H Tighe; D Lee; M Corr; M D Nguyen; G J Silverman; M Lotz; D A Carson; E Raz
Journal:  Science       Date:  1996-07-19       Impact factor: 47.728

5.  CTL in mice immunized with human mucin 1 are MHC-restricted.

Authors:  V Apostolopoulos; B E Loveland; G A Pietersz; I F McKenzie
Journal:  J Immunol       Date:  1995-12-01       Impact factor: 5.422

6.  Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA.

Authors:  K R Jerome; N Domenech; O J Finn
Journal:  J Immunol       Date:  1993-08-01       Impact factor: 5.422

7.  Murine immune response to cells transfected with human MUC1: immunization with cellular and synthetic antigens.

Authors:  V Apostolopoulos; P X Xing; I F McKenzie
Journal:  Cancer Res       Date:  1994-10-01       Impact factor: 12.701

8.  Does pregnancy immunize against breast cancer?

Authors:  B Agrawal; M A Reddish; M J Krantz; B M Longenecker
Journal:  Cancer Res       Date:  1995-06-01       Impact factor: 12.701

9.  Heterogeneity of mucin gene expression in normal and neoplastic tissues.

Authors:  S B Ho; G A Niehans; C Lyftogt; P S Yan; D L Cherwitz; E T Gum; R Dahiya; Y S Kim
Journal:  Cancer Res       Date:  1993-02-01       Impact factor: 12.701

10.  MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma.

Authors:  S Nakamori; D M Ota; K R Cleary; K Shirotani; T Irimura
Journal:  Gastroenterology       Date:  1994-02       Impact factor: 22.682

View more
  6 in total

1.  Unique Glycoform-Dependent Monoclonal Antibodies for Mouse Mucin 21.

Authors:  Jun Nishida; Shigeyuki Shichino; Tatsuya Tsukui; Mayumi Hoshino; Tomoko Okada; Kyoko Okada; Yuri Yi; Seiko Toraya-Brown; Miho Mochizuki; Ryouta Koizumi; Katrin Ishii-Schrade; Kaori Denda-Nagai; Tatsuro Irimura
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

2.  Immunization with a vaccine that combines the expression of MUC1 and B7 co-stimulatory molecules prolongs the survival of mice and delays the appearance of mouse mammary tumors.

Authors:  Vitaly Vasilevko; Anahit Ghochikyan; Nadya Sadzikava; Irina Petrushina; Mike Tran; Edward P Cohen; Patrick J Kesslak; David H Cribbs; Garth L Nicolson; Michael G Agadjanyan
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

Review 3.  MUC1 and metastatic cancer: expression, function and therapeutic targeting.

Authors:  Teresa M Horm; Joyce A Schroeder
Journal:  Cell Adh Migr       Date:  2013-01-09       Impact factor: 3.405

4.  Local effects of regulatory T cells in MUC1 transgenic mice potentiate growth of MUC1 expressing tumor cells in vivo.

Authors:  Daisuke Sugiura; Kaori Denda-Nagai; Mitsuyo Takashima; Ryuichi Murakami; Shigenori Nagai; Kazuyoshi Takeda; Tatsuro Irimura
Journal:  PLoS One       Date:  2012-09-17       Impact factor: 3.240

Review 5.  DNA vaccination: using the patient's immune system to overcome cancer.

Authors:  Georg Eschenburg; Alexander Stermann; Robert Preissner; Hellmuth-Alexander Meyer; Holger N Lode
Journal:  Clin Dev Immunol       Date:  2010-12-16

6.  Altered glycosylation of MUC1 influences its association with CIN85: the role of this novel complex in cancer cell invasion and migration.

Authors:  Sandra Cascio; Adam M Farkas; Rebecca P Hughey; Olivera J Finn
Journal:  Oncotarget       Date:  2013-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.